New Jersey In Focus After Congress Delays Bill
Hopes remain high that major regulatory changes are coming
With a major piece of pro-cannabis legislation now likely to be heard after the U.S. presidential election, the industry is turning its attention to a new hope: a domino effect in the Northeast.
The Marijuana Opportunity Reinvestment and Expungement Act, known as the MORE Act, won’t go to the U.S. House this week, and is instead expected to go to a vote sometime in the lame-duck session between the Nov. 3 election and inauguration on Jan. 20. The bill would take marijuana off the list of controlled substances and expunge prior convictions for it. While the initiative has gained traction — it has more than 100 co-sponsors, including a few Republicans — it has become a victim of the electoral season.
But hopes remain high that major regulatory changes are coming within the next few years.
“The electability of cannabis is clear –- Americans overwhelmingly support this issue and members of Congress shouldn’t shy away from it,” said David Culver, a vice president at Canopy Growth Corp. Speaking during an online discussion last week on cannabis, Culver said that Democrats were concerned about the optics of reaching a decision on cannabis legislation before Covid-19 relief is approved.
To Read The Rest Of This Article On Bloomberg, Click Here
